Eliyahu Sharon Kalif insider trades
Open-market stock purchases and sales by Eliyahu Sharon Kalif, EVP, Chief Financial Officer at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Feb 13, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $3.6M |
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $5.5M |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 3, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Mar 3, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
| Feb 26, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Sold | $11.6M |
| Jan 27, 2026 | TEVA Teva Pharmaceutical Industries Ltd | Bought (not open market) | — |
Companies traded
- TEVA Teva Pharmaceutical Industries Ltd: 8 sales, last Jun 11, 2026
Get free alerts when Eliyahu Sharon Kalif files a new trade →